Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Geographic Atrophy Secondary to Age-related Macular Degeneration”

86 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 86 results

Testing effectiveness (Phase 2)Ended earlyNCT02087085
What this trial is testing

A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Geographic AtrophyMacular Degeneration
Allergan 310
Not applicableEnded earlyNCT03935126
What this trial is testing

Global Atrophie Biomarker Evaluation Study (GABiE)

Who this might be right for
Age-related Macular Degeneration
Boehringer Ingelheim 3
Large-scale testing (Phase 3)Study completedNCT07214740
What this trial is testing

Study to Evaluate a Pegcetacoplan (Syfovre®) Prefilled Syringe

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Apellis Pharmaceuticals, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT02613572
What this trial is testing

Alpha Lipoic Acid in Geographic Atrophy

Who this might be right for
Age-Related Macular Degeneration
University of Pennsylvania 68
Testing effectiveness (Phase 2)WithdrawnNCT03446144
What this trial is testing

Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic AtrophyAge Related Macular Degeneration
Ionis Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT05893537
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Who this might be right for
Age-Related Macular Degeneration
Cognition Therapeutics 100
Early research (Phase 1)Ended earlyNCT04002310
What this trial is testing

Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy

Who this might be right for
Macular Degeneration
Boehringer Ingelheim 18
Testing effectiveness (Phase 2)Looking for participantsNCT06990269
What this trial is testing

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
ADARx Pharmaceuticals, Inc. 240
Testing effectiveness (Phase 2)Study completedNCT01226628
What this trial is testing

A Safety Study of CNTO 2476 in Patients With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Janssen Research & Development, LLC 39
Testing effectiveness (Phase 2)Study completedNCT01342926
What this trial is testing

Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Atrophy, Geographic
GlaxoSmithKline 191
Early research (Phase 1)Study completedNCT04246866
What this trial is testing

First in Human Study to Evaluate the Safety and Tolerability of GEM103 in Geographic Atrophy Secondary to Dry Age Related Macular Degeneration

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyMacular Degeneration+2 more
Gemini Therapeutics, Inc. 12
Not applicableStudy completedNCT01799564
What this trial is testing

Micropulse Laser for Geographic Atrophy

Who this might be right for
Geographic AtrophyAge-related Macular Degeneration
Institut de la Macula y la Retina 11
Not applicableLooking for participantsNCT06779773
What this trial is testing

Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy

Who this might be right for
Geographic AtrophyMacular Degeneration
Astellas Pharma Global Development, Inc. 500
Testing effectiveness (Phase 2)Looking for participantsNCT07174687
What this trial is testing

SGLT2 Inhibitors in Geographic Atrophy

Who this might be right for
Retinal DegenerationRetinal DiseasesEye Diseases+2 more
Washington University School of Medicine 70
Testing effectiveness (Phase 2)Ended earlyNCT04566445
What this trial is testing

HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

Who this might be right for
Dry Age-related Macular Degeneration
Gyroscope Therapeutics Limited 255
Not applicableNot Yet RecruitingNCT07570355
What this trial is testing

Pterygopalatine Ganglion Stimulation for the Treatment of Geographic Atrophy

Who this might be right for
Geographic Atrophy
Shanghai Institute of Acupuncture, Moxibustion and Meridian 62
Testing effectiveness (Phase 2)Looking for participantsNCT07392255
What this trial is testing

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

Who this might be right for
Geographic Atrophy Secondary to Age-related Macular Degeneration
Complement Therapeutics 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT06018558
What this trial is testing

Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy

Who this might be right for
Geographic Atrophy
Ocugen 60
Not applicableActive Not RecruitingNCT05797896
What this trial is testing

Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyRetinal Disease+4 more
Complement Therapeutics 250
Large-scale testing (Phase 3)Study completedNCT04005352
What this trial is testing

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 734
Load More Results